Let’s review a new drug!
✨You guys! – my new favorite hobby is mind mapping so let’s take a minute and learn about a new injectable diabetes medication together using this tool.
💉Mounjaro (generic name: tirzepatide) is a new injectable medication indicated for Type 2 Diabetes. It is also called an Incretin mimetic.
🤔But what is incretin?
Incretin is a hormone or peptide that gets secreted by the gut in response to ingested food (helps the body regulate glucose). You can think of incretin as an acronym for:
🧠INtestinal seCRETion of INsulin in response to food.
The two most important incretins in our body account for 90% of all incretin hormones:
👉🏻GLP-1 (glucagon-like peptide 1)
👉🏻GIP (glucose-dependent insulinotropic peptide)
To understand the mechanism of action of tirzepatide, you need to understand what GLP-1 and GIP do.
GIP-1 and GIP help to regulate glucose control in the body by increasing insulin secretion, delaying gastric emptying, and activating the satiety center in the brain (makes us feel full)
⭐️Tirzepatide is unique from other incretin mimetics because it has a dual mechanism of action by working on both GLP-1 and GIP.
👉🏻You can get your own mind map worksheet here!